Pre-treatment predictors of response for assessing outcomes to standard treatment in infection with HCV genotype 3.

Objective: To determine the role of pre-treatment predictors of response in assessing outcomes to standard treatment in HCV genotype 3.

Study Design: Observational study.

Place And Duration Of Study: Department of Medicine, KRL General Hospital, Islamabad, from December 2004 to December 2006.